Skip to content

AxiumTM FC-4-12-3DRecalls & reported problems

Micro Therapeutics, Inc. · FRAMING COIL FC-4-12-3D V01 · Class 2 · Implant

All models of AxiumTM (139)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00847536022911), received between May 4, 2021 and May 4, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Separation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Separation Failure1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 4, 2021Separation Failure; Separation Failure

    ADDITIONAL INFORMATION RECEIVED REPORTED THERE WAS NO ISSUE WITH THE INSTANT DETACHER WHICH WAS USED SUCCESSFULLY WITHOUT ISSUE WITH ANOTHER COIL. NO OTHER ISSUES OCCURRED PRIOR TO THE COIL NON-DETACHMENT. NO DAMAGE TO THE COIL PUSHWIRE WAS NOTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11772934 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page